smallAccCompHo_0921.xslt
Company Registration No. 13073074 (England and Wales)
DANTE GENOME HOUSE LTD
Financial Statements
for the Period from 01 January 2025 to 31 December 2025

DANTE GENOME HOUSE LTD

Financial Statements for the period ending 31 December 2025

CONTENTS PAGE
Company Information 2
Statement of Financial Position 3
Notes to the Accounts 4
- 1 -

DANTE GENOME HOUSE LTD

Financial Statements for the period ending 31 December 2025

Company Information

Company Details
Company Number 13073074
Registered Office 86-90 PAUL STREET 3RD FLOOR
LONDON
EC2A 4NE
Directors
Directors who held office during the period were:
Andrea RIPOSATI   
- 2 -

DANTE GENOME HOUSE LTD

Financial Statements for the period ending 31 December 2025

Statement of Financial Position

12345678
Notes 2025 2024
£ £
Fixed Assets
Investments 5 2,573,005 2,540,964
Current Assets
Debtors due 191,343 531,137
Cash at bank and in hand 31 15
191,374 531,152
Creditors
Amount falling due within one year (64,608) (104,246)
Net Current Assets 126,766 426,906
Total Assets less current liabilities 2,699,771 2,967,870
Creditors due after more than one year (2,265,191) (4,476,990)
Net Assets 434,580 (1,509,120)
Capital and Reserves
Called up Share Capital 1,000 1,000
Share Premium Account 2,065,617 400,000
Retained earnings at end of year (1,632,037) (1,910,120)
Shareholder funds 434,580 (1,509,120)
For the year ending 31/12/2025 the company was entitled to exemption under section 477 of the Companies Act 2006 relating to small companies.
The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The members have agreed to the preparation of abridged accounts for this accounting period in accordance with Section 444(2A).
The Directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared in accordance with the provisions applicable to companies subject to the small companies' regime and in accordance with the provisions of FRS 102 Section 1A - Small Entities.
Approved by the Board on 24 July 2026
Andrea Riposati
Company Registration No. 13073074
- 3 -

DANTE GENOME HOUSE LTD

Financial Statements for the period ending 31 December 2025

Notes to the Accounts

1. Statutory Information
DANTE GENOME HOUSE LTD is a private company, limited by shares, registered in England and Wales, registration number 13073074.
2. Accounting Policies
Basis of preparing the Financial Statements
The accounts have been prepared in accordance with the provisions of FRS 102 Section 1A Small Entities.
Presentation Currency
The accounts are presented in £ sterling.
- 4 -

DANTE GENOME HOUSE LTD

Financial Statements for the period ending 31 December 2025

Notes to the Accounts

3. Employees
Average number of employees, including directors, during the year was as follows:
2025 1
2024 2
4. Principal Activity
The company develops solutions for genomics analysis in research use (RUO) and clinical use, in the life sciences and genomics sector.
- 5 -

DANTE GENOME HOUSE LTD

Financial Statements for the period ending 31 December 2025

Notes to the Accounts

5. Investments
Investments in Subsidiaries Other Investments - Listed Other Investments -Unlisted Total
£ £ £ £
Valuation at 01/01/2025 2,573,005 - - 2,573,005
Additions - - - -
Disposals - - - -
Adjustments - - - -
Valuation at 31/12/2025 2,573,005 - - 2,573,005
- 6 -